610 filings
Page 16 of 31
4
BLPH
Bellerophon Therapeutics, Inc.
17 Sep 18
Bellerophon Therapeutics / ASSOCIATES IV L P VENROCK ownership change
12:00am
4
BLPH
Bellerophon Therapeutics, Inc.
17 Sep 18
Bellerophon Therapeutics / ASSOCIATES IV L P VENROCK ownership change
12:00am
4
BLPH
Bellerophon Therapeutics, Inc.
12 Sep 18
Bellerophon Therapeutics / Nimish P Shah ownership change
12:00am
4
BLPH
Bellerophon Therapeutics, Inc.
12 Sep 18
Bellerophon Therapeutics / ENTREPRENEURS FUND IV L P VENROCK ownership change
12:00am
4
BLPH
Bellerophon Therapeutics, Inc.
7 Sep 18
Bellerophon Therapeutics / Nimish P Shah ownership change
12:00am
4
BLPH
Bellerophon Therapeutics, Inc.
7 Sep 18
Bellerophon Therapeutics / ASSOCIATES IV L P VENROCK ownership change
12:00am
8-K
BLPH
Bellerophon Therapeutics, Inc.
5 Sep 18
Regulation FD Disclosure
12:00am
SC 13G/A
BLPH
Bellerophon Therapeutics, Inc.
20 Aug 18
Bellerophon Therapeutics, Inc.
12:00am
4
Shah Nimish P
16 Aug 18
Bellerophon Therapeutics / ASSOCIATES IV L P VENROCK ownership change
7:33pm
4
VHCP Co-Investment Holdings II, LLC
16 Aug 18
Bellerophon Therapeutics / Bong Y Koh ownership change
7:31pm
3
Shah Nimish P
16 Aug 18
Bellerophon Therapeutics / ASSOCIATES IV L P VENROCK ownership change
7:29pm
3
VHCP Co-Investment Holdings II, LLC
16 Aug 18
Bellerophon Therapeutics / Bong Y Koh ownership change
7:28pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
13 Aug 18
Departure of Directors or Certain Officers
12:00am
8-K
BLPH
Bellerophon Therapeutics, Inc.
7 Aug 18
Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse® for Treatment of Pulmonary Arterial Hypertension
8:36am
8-K
BLPH
Bellerophon Therapeutics, Inc.
1 Aug 18
Bellerophon Provides Business Update and Reports Second Quarter 2018 Financial Results
8:40am
424B2
BLPH
Bellerophon Therapeutics, Inc.
17 Jul 18
Prospectus for primary offering
4:26pm
EFFECT
BLPH
Bellerophon Therapeutics, Inc.
9 Jul 18
Notice of effectiveness
12:19am
UPLOAD
BLPH
Bellerophon Therapeutics, Inc.
3 Jul 18
Letter from SEC
12:00am
CORRESP
BLPH
Bellerophon Therapeutics, Inc.
3 Jul 18
Correspondence with SEC
12:00am